what role do markers play in establishing active surveillance or definitive care?
Published 4 years ago • 184 plays • Length 12:46Download video MP4
Download video MP3
Similar videos
-
23:37
active surveillance who is the right patient and what is the right protocol
-
13:24
genetics and genomic biomarkers: how molecular markers and mpmri play a role
-
20:39
active surveillance or: shrinking the gray zone
-
12:19
active surveillance 2022: who qualifies, who does not and how should it be monitored
-
1:58
integrated diagnostics and patient selection for active surveillance and treatment
-
11:39
urologic debate part 2: mri vs. molecular markers: which one should i use? markers perspective
-
13:31
diagnosing renal masses: do advanced imaging techniques and biomarkers play an important role?
-
9:59
point-counterpoint: active surveillance for intermediate-risk prostate cancer - con
-
26:20
mapping pathology as a guide to focal therapy the role of mapping biopsies and tissue markers
-
29:23
how should we monitor patients during surveillance?
-
6:09
germline testing for prostate cancer active surveillance
-
14:48
urinary markers in nmibc what's new youtube
-
26:28
active surveillance from biology to bedside
-
17:36
forward progress in molecular markers for prostate cancer
-
17:40
when to biopsy: the role for psa and novel biomarkers
-
9:02
focal therapy for localized pca: is there a middle ground between active surveillance and treatment
-
7:26
pc markers algorithm
-
16:33
the when and how of post-ablation surveillance
-
15:42
urinary markers in bladder cancer